Eyitayo S. Fakunle, Ph.D., Head of Translational Research

Dr. Eyitayo "Tayo" Fakunle joins CalAsia Pharmaceuticals from a multidisciplinary background that encompasses engineering, analytical chemistry, stem cell technology, and public health. Dr. Fakunle received her doctorate from the University of Arkansas, Fayetteville, Arkansas. She conducted her postdoctoral training at the University of California San Diego, Department of Bioengineering, La Jolla, followed by further training at the Scripps Research Institute's Center for Regenerative Medicine , La Jolla. In 2008, Dr. Fakunle founded IFASEMB, a Nongovernmental Organization (NGO), whose mission is to address global health disparities by fostering partnerships in science, engineering, medicine, and beyond. As head of translational research, Dr. Fakunle will manage, lead, and oversee the setup of stem cell-based compound screening as part of CalAsia's drug discovery platform. This approach will accelerate CalAsia's goal to achieve early proof of principle on lead compounds for efficient and rapid transition into preclinical and clinical development studies. Furthermore, she will lead educational activities in stem cell technology, including hands on training. She will also initiate collaborations and partnerships with academia, industry, and NGO's and will promote CalAsia locally, nationally, and internationally as a leader in drug discovery aimed at addressing the need for better treatments to meet unmet medical needs.